Metabolic syndrome and heart failure: data from the FADOI CONFINE study

Submitted: 5 July 2013
Accepted: 12 September 2013
Published: 19 September 2014
Abstract Views: 1471
PDF: 814
HTML: 292
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Approximately 20%-30% of the population in industrialized countries suffers from metabolic syndrome (MetS), a condition that may double the risk of diabetes mellitus and heart diseases in the normal population. Both MetS per se and its components increase the risk of atherosclerosis and acute coronary artery disease and heart failure (HF). We reviewed the data from a recent survey of patients admitted to Italian internal medicine wards due to chronic heart failure to ascertain the prevalence and the relationships between MetS and HF in real life patients. Our data shows that some risk factors for this syndrome (above all obesity) reflect a sort of Janus phenomenon in that they are well-recognized risk factors for HF in young people, but they lose their unfavorable predictive value in elderly patients with HF.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Biagi, P., Nardi, R., Mathieu, G., Vescovo, G., Scanelli, G., & CONFINE Study Group, on behalf of the. (2014). Metabolic syndrome and heart failure: data from the FADOI CONFINE study. Italian Journal of Medicine, 8(3), 169–175. https://doi.org/10.4081/itjm.2014.406

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.